INDY (iShares S&P India Nifty 50 Index Fund) Stock Analysis - News

iShares S&P India Nifty 50 Index Fund (INDY) is a publicly traded the market company. As of May 21, 2026, INDY trades at $42.46 with a market cap of $0 and a P/E ratio of 0.00. INDY moved +1.44% today. Year to date, INDY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces INDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in INDY news today?

Oil Surges 4% on Iran Tensions, Weighs on India 50 ETF: Analysts warn that oil prices rose over 4% on Feb. 18 after U.S. officials signaled possible military action against Iran, driving energy import costs higher for India and threatening iShares India 50 ETF’s returns. Elevated crude also squeezes Indian consumer and airline sectors, amplifying headwinds for the ETF.

INDY Key Metrics

Key financial metrics for INDY
MetricValue
Price$42.46
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume132.07K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest INDY News

INDY Analyst Consensus

INDY analyst coverage data. Average price target: $0.00.

Common questions about INDY

What changed in INDY news today?
Oil Surges 4% on Iran Tensions, Weighs on India 50 ETF: Analysts warn that oil prices rose over 4% on Feb. 18 after U.S. officials signaled possible military action against Iran, driving energy import costs higher for India and threatening iShares India 50 ETF’s returns. Elevated crude also squeezes Indian consumer and airline sectors, amplifying headwinds for the ETF.
Does Rallies summarize INDY news?
Yes. Rallies summarizes INDY news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is INDY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INDY. It does not provide personalized investment advice.
INDY

INDY